4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001562180-21-005521
Chief Executive Officer acquired 23,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GOTTSCHALK ADRIAN Chief Executive Officer | 2021-08-20 | Option exercise | +23,000 | $0.54 | $12,420 | 446,479 | D |
| Derivatives | |||||||
| GOTTSCHALK ADRIAN Chief Executive Officer | 2021-08-20 | Option exercise · Stock Options (Right to buy) | −23,000 | 458,925 | D | ||
Loading xslF345X03/primarydocument.xml…